Paul Allen says non-Hodgkin’s lymphoma has returned but voices optimism about fighting it Nine years after he underwent treatment for non-Hodgkin’s lymphoma, a potentially fatal but treatable form of cancer, Microsoft co-founder Paul… Read More
Study of Juno Therapeutics cancer treatment shows high rates of remission, possible promise for other drugs A study published today on a Juno Therapeutics immunotherapy treatment for blood cancers shows that the drug and others like it could… Read More
